Mind Uncharted Explore. Discover. Learn.
Tivic Health Announces Pricing of $1.4 Million Public Offering of…
Tivic Health, a leading bioelectronic device company, has recently announced the pricing of its public offering of common stock. The company aims to raise $1.4 million through this offering.
Founded in 2016, Tivic Health focuses on developing innovative therapy solutions for chronic diseases. The company’s flagship product, ClearUP™ Sinus Pain Relief, provides a non-invasive and drug-free solution for individuals suffering from sinus pain.
The Public Offering
Tivic Health plans to offer a total of 1,000,000 shares of common stock, with the price per share set at $1.40. The offering will be conducted on a best-efforts basis, and all shares will be offered by the company itself. The gross proceeds from the offering are expected to be $1.4 million, before deducting underwriting discounts and other estimated expenses.
Intended Use of Proceeds
The proceeds from the offering will be used by Tivic Health for various purposes, including the commercialization of ClearUP™ Sinus Pain Relief. The funds will also support product development, manufacturing, working capital, and other general corporate purposes.
About ClearUP™ Sinus Pain Relief
ClearUP™ Sinus Pain Relief is an FDA-approved device that utilizes gentle microcurrent waveforms to provide relief from sinus pain. The handheld device is designed to be used externally on the cheek, nose, and brow bone. It works by targeting the sinus nerve pathways and providing quick relief without the use of drugs or invasive procedures.
The portable nature of ClearUP™ allows it to be used in a variety of settings, making it an ideal solution for individuals seeking immediate relief from sinus pain. The device is suitable for use at home, in the office, or even while traveling.
Advantages of ClearUP™ Sinus Pain Relief
ClearUP™ offers several advantages over other traditional methods of sinus pain relief. Firstly, it is a non-invasive solution, eliminating the need for surgery or complicated procedures. Additionally, it does not rely on medication, which can have potential side effects.
The device is user-friendly, requiring only a few minutes of treatment for each session. It provides immediate relief and can be used as often as needed throughout the day. ClearUP™ is also portable and rechargeable, making it convenient and accessible for individuals on the go.
Conclusion
Tivic Health’s successful pricing of the $1.4 million public offering marks an important milestone for the company. With the funds raised, Tivic Health aims to further develop and promote its innovative solution, ClearUP™ Sinus Pain Relief. This non-invasive and drug-free device has the potential to improve the quality of life for individuals suffering from chronic sinus pain.
